Jade Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	827	761	341	628	724	288
Market Cap Growth	-	123.38%	-45.78%	-13.27%	151.70%	-
Enterprise Value	491.23	513.96	448.25	506.09	595.87	120.81
Last Close Price	16.76	15.43	92.75	792.05	1025.50	412.65
PE Ratio	-	-4.84	-1.09	-7.89	-13.95	-6.30
PB Ratio	2.49	5808.78	-	5.74	5.72	1.67
P/TBV Ratio	4003.25	3693.77	-	5.44	5.66	0.84
P/FCF Ratio	-	-8.02	-4.78	-11.04	-18.42	-10.44
P/OCF Ratio	-	-8.04	-4.78	-11.07	-18.52	-10.50
EV/EBITDA Ratio	-	-4.53	-6.03	-6.22	-11.21	-5.25
EV/EBIT Ratio	-	-4.53	-6.01	-6.22	-11.19	-5.25
EV/FCF Ratio	-	-5.42	-6.30	-8.89	-15.16	-4.38
Debt / Equity Ratio	5.53	5.53	53800.00	0.00	0.01	0.00
Debt / EBITDA Ratio	-0.01	-0.01	-1.45	-0.01	-0.02	-0.02
Debt / FCF Ratio	-0.01	-0.01	-1.51	-0.01	-0.03	-0.02
Net Debt / Equity Ratio	-1885.47	-1885.47	-	-1.11	-1.01	-0.97
Net Debt / EBITDA Ratio	2.64	2.18	-1.45	1.50	2.41	7.25
Net Debt / FCF Ratio	2.60	2.60	-1.51	2.14	3.26	6.05
Quick Ratio	14.98	14.98	0	6.94	16.60	65.64
Current Ratio	21.09	21.09	5.81	7.04	16.90	68.37
Return on Equity (ROE)	-137983.46%	-191593.98%	-127.22%	-63.95%	-34.44%	-26.19%
Return on Assets (ROA)	-44.25%	-53.71%	-74.57%	-62.02%	-34.29%	-25.57%
Return on Invested Capital (ROIC)	-126.84%	-153.99%	-300.77%	1202.15%	-2469.30%	-1151.83%
Return on Capital Employed (ROCE)	-47.48%	-57.63%	-87.46%	-68.61%	-35.45%	-26.20%
Earnings Yield	-12.12%	-20.67%	-92.08%	-12.68%	-7.17%	-15.86%
FCF Yield	-11.48%	-12.47%	-20.90%	-9.06%	-5.43%	-9.58%
Buyback Yield / Dilution	-	-3740.15%	-8.55%	-7.60%	-99.06%	-4975.15%
Total Shareholder Return	-	-3740.15%	-8.55%	-7.60%	-99.06%	-4975.15%

Updated Mar 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q